INTRODUCTION
The high voltage-activated Ca 2+ channels (HVACCs) play a key role in cellular process under physical, chemical and inflammatory damage in peripheral tissues [1] ; they are classified into L-, N-, P/Q-and R-type Ca 2+ channels on the basis of pharmacological and electrophysiological properties in sensory neurons such as dorsal root ganglion (DRG) and trigeminal ganglion (TG) neurons [2, 3] . HVACCs are formed by one of a number of pore-forming α1 subunits, α1A∼F and α1S, in addition to auxiliary subunits. Molecular characterizations have determined that α1C, α1D, α1F, and α1S subunits encode L-type (Cav1.1, 1.2, 1.3 and 1.4) channels [4] ; α1A encodes P/Q-type (Cav2.1) channels [5] ; α1B encodes N-type (Cav2.2) channels [6] ; α1E encodes R-type (Cav2.3) channels [7] .
Six isoforms of the R-type Cav2.3 Ca 2+ channel (Cav2.3a∼ Cav2.3f) have been reported in various mammalian species [8] [9] [10] [11] [12] . R-type Ca 2+ channels are also present in DRG neurons [2] , and have been suggested to play a critical role in the pain transmission and neuropathic pain [13, 14] . Immunohistochemical and in situ hybridization analysis also showed differential expression of R-type Ca 2+ channels in DRG neurons [15, 16] . In the previous study, we demonstrated that Cav2.3e is the major Cav2.3 isoform in the nociceptive TG neurons, the counterpart of DRG neurons in the orofacial area [17] . However, to date, expression patterns of R-type Cav2.3 Ca 2+ channel in DRG neurons have not been characterized.
In the present study, we determined the Cav2.3 isoforms uniquely expressed in rat nociceptive DRG neurons by using whole-tissue RT-PCR and single-cell RT-PCR. Our results show that Cav2.3 isoform in nociceptive DRG neurons is comparable to that of TG neurons; Cav2.3e is the major R-type Cav2.3 isoform in nociceptive DRG neurons and is preferentially expressed in IB4-negative, trkA-positive and TRPV1-positive neurons.
METHODS

Preparation of DRG neurons
All surgical and experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) in School of Dentistry, Seoul National University. DRG neurons from 2-to 5-day old neonatal rats were prepared as previously described [18] . Briefly, DRGs were rapidly removed from spinal segments and digested sequentially in collagenase (Sigma, St. Louis, MO), dispase (Boe-Z Fang, et al 
Whole tissue Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Analysis
Total RNA was isolated from 2-to 5-day-old rats DRG by using the Trizol reagent (Life Technologies). Following digestion with DNase I, 3μg of total RNA was used for cDNA synthesis using the Superscript First-Strand Synthesis System (Invitrogen, Carlsbad, California). After reverse transcription of total RNA, 1 ng of cDNA was then used as a template for amplification in a reaction mixture. As shown in our previous study [17] , primers for PCR were specifically designed to differentiate the presence or the absence of three inserts (inserts I, II and III) on the Cav2. As a positive control, cDNA from the same preparations was subjected to 35 cycles of PCR with primers for β-actin. All PCR products were resolved on 2% agarose gel.
Single-cell RT-PCR
The entire single cell was aspirated into a pipette under visual control via negative pressure. Pipettes used for entire neuron harvest had a tip diameter range of 12∼30μm, and was filled with RNase-free water. The tip of the pipette and its contents were broken into a reaction tube containing reverse transcription (RT) reagents. To avoid genomic DNA contamination, digestion with DNase was performed before RT. RT was carried out for 1 h at 50 o C (Invitrogen) and the cDNA product was used in separate PCR. The forward and reverse primers were chosen from parts specific to the gene to be detected in order to avoid amplification of closely homologous genes. The first round of PCR was preformed in 50μl of PCR buffer containing 0.2 mM dNTPs, 0.2μM "outer" primers, 5μl of RT product, and 0.2μl of platinum Taq DNA polymerase (Invitrogen). The protocol included 5 min of initial denaturation step at 95 o C, 40 s of elongation at 72 o C, and was completed with 7 min of final elongation. For the second round of amplification, the reaction buffer (20μl) contained 0.2 mM dNTPs, 0.2μM "inner" primers, 5μl of the products from the first round PCR, and 0.1μl of platinum Taq DNA polymerase. The reaction procedure was the same as the first round. "Insert" primers, designed to detect the presence of insert fragments, were also used in second round amplifications. For the positive controls, β-actin primers were used in parallel in each PCR reaction. Negative control was obtained from pipettes that did not harvest any cell contents but were submerged in bath solution. The PCR products were displayed on ethidium bromide-stained 2% agarose gel. Gels were photographed using a digital camera (Bio-print 2000 x-press zoom, Vilber Lourmat, France).
Classification of sensory neurons
DRG neurons are classified into three groups, small-sized (＜16μm), medium-sized (16∼20μm) and large-sized (20 ∼30μm) neurons [19] . Griffonia simplicifolia isolectin B4 (IB4) was also utilized to classify DRG neurons into either IB4-positive or IB4-negative neurons [20] . Before single cell collection, DRG cells were incubated with 10μg/ml IB4-FITC (Sigma) in a balanced salt solution [(in mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose] for 10 min and then rinsed. 
RESULTS
Presence of Cav2.3 isoforms Cav2.3a and Cav2.3e in DRG neurons
In order to determine Cav2.3 isoform in DRG neurons, we utilized the same strategy, as previously done in TG neurons [17] , which examined the presence or the absence of three major inserts: insert I, insert II in the II-III loop, and insert III in the carboxy terminus (Fig. 1A) . Using both "inner" primers and "insert" primers, the PCR products were differentiated by size and additionally by the presence of the insert region (Fig. 1C) . For the II-III loop, the PCR amplification only yielded Cav2.3 isoforms containing insert II but lacking insert I. However, PCR amplification of the carboxy terminus we could detect both shorter cDNA fragments that lack insert III and longer cDNA fragments that contain insert III. These two isoforms were Cav2.3a and Cav2.3e splice variants, respectively (Fig. 1B) .
The prominance of Cav2.3e in DRG neurons
Given that only two isoforms of Cav2.3-Cav2.3a and Cav2.3e splice variants were present in DRG, we then determined the expression patterns of these two isoforms at the single cell level. By using single-cell RT-PCR, we detected Cav2.3a and Cav2.3e mRNA in subpopulations of DRG neurons, which was in good agreement with whole-tissue RT-PCR (Fig. 2A) . Since Cav2.3a and Cav2.3e differ only in the presence or absence of insert III, we analyzed insert III to discriminate their expression in individual cells. Cav2.3e and Cav2.3a mRNAs were detected in 20.0% (n=14) and 2.8% (n=2) of neurons, respectively (n=70; Fig. 2B ). Likewise in TG neurons, we found that Cav2.3e was the prominant isoform of Cav2.3 in DRG neurons but did not observe any DRG neurons that co-expressed both Cav2.3e and Cav2.3a in the same cells.
Preferential Expression of Cav2.3e isoform in trkApositive, IB4-negative and TRPV1-positive small-sized DRG neurons
Neonatal DRG neurons can be classified into small-, medium-and large-sized neurons, with the small-sized neurons functioning as nociceptors [21] . Cav2.3e mRNA was detected in 30.0% (n=12/40) of small-sized neurons, 13.3% (n=2/15) of medium-sized neurons, and 0% (n=0/15) of large-sized neurons (Fig. 3) . These results indicate that Cav2.3e is prominently expressed in nociceptive DRG neurons as Cav2.3e mRNA was mainly detected in small-sized neurons (n=12/14), but in only a few medium-sized neurons (n=2/14) and not in large-sized neurons.
Small-diameter sensory neurons can be divided into two types based on their neurochemical properties [22] . One group contains neuropeptides such as calcitonin-gene related neuropeptide (CGRP) and substance P, and express the high-affinity nerve growth factor (NGF) receptor trkA; the other group lacking neuropeptides instead possess fluoride-resistant acid phosphatase (FRAP) activity, bind the plant lectin isolectin B4 (IB4) and are positive for the ATP-gated ionotropic receptor P2X3 [23] [24] [25] . We used an IB4-FITC conjugate to distinguish IB4-positive small-sized DRG neurons (n=40). IB4-positive neurons (80% of which expressed P2X3 mRNA) did not contain Cav2.3e mRNA (n=10). Of the small diameter IB4-negative neurons, 80% expressed trkA mRNA; Cav2.3e (n=12/24) was only detected in trkA-positive neurons (Fig. 4A) . We also examined whether Cav2.3e mRNAs are expressed together with TRPV1 in small neurons. 66.7% (n=8/12) of neurons expressing Cav2.3e mRNA were TRPV1-positive, while 14.3% of neurons lacking Cav2.3e mRNA were TRPV1-negative (Fig. 4B ).
DISCUSSION
Our recent study revealed that Cav2.3e expression is highly restricted to small (＜16μm) IB4-negative, trkApositive, and TRPV1 TG neurons [17] . In the present study, we determined expression patterns of Cav2.3 isoform in DRG neurons. We found that Cav2.3a and Cav2.3e isoforms were present in DRG neurons. Among these two isoforms, Cav2.3e was the major isoform preferentially expressed in small-sized TRPV1-positive nociceptive neurons and was restricted to IB4-negative and trkA-positive neurons. These results suggest that the expression patterns of Cav2.3 isoforms in nociceptive DRG neurons are similar to those of TG neurons; the strong presence of Cav2.3e mRNA may correlate with the expression of the R-type Ca 2+ channel, which might play a critical role in pain transmission in DRG neurons [26] .
Among six isoforms (Cav2.3a, Cav2.3b, Cav2.3c, Cav2.3d, Cav2.3e, Cav2.3f), Cav2.3e is the major endocrine Cav2.3 isoform that was identified in rat and human kidney, insulinoma cell line INS-1 cells and islets of Langerhans [10] . We have shown that Cav2.3e is uniquely expressed in trkA-positive, IB4-negative DRG neurons that contain neuropeptide transmitters such as substance P and CGRP. Based on these results, Cav2.3e might be an important molecular mediator in neuropeptide release from nociceptive nerve terminals, in which case Cav2.3e may be the major Cav2.3 isoform responsible for the nociception mediated by Cav2.3 in the spinal system.
In accordance with our previous work in TG neurons [17] , Cav2.3e-expressing DRG neurons also exhibited several properties of nociceptors, such as being of small-diameter, IB4-negative and positive for TRPV1 and trkA. It has been reported that α1E subunits were heterogeneously localized in the cell bodies of the DRG neurons in immunohistochemistry [15] and in situ hybridization [16] . Cav2.3e expression at a higher level in the small-sized DRG neurons suggests that Cav2.3e might have distinctive role in transduction of pain in nociceptive neurons. Also, restricted distribution of Cav2.3e to trkA-positive/IB4-negative nociceptors, but not to P2X3-positive/IB4-positive neuron, suggests that these two populations may transmit pain information to the spinal cord in different manners that are possibly mediated by the participation of different Ca 2+ channel isoforms. However, it remains to be determined the exact functional role of preferential Cav2.3e expression in trkA-positive/IB4-negative and TRPV1-positive neurons.
R-type Ca 2+ channels are associated with nociceptive processing in various pain conditions. Mathews et al reported that spinal SNX-482, a Cav2.3 Ca 2+ channel blocker, inhibited noxious C-fiber and Aδ-fiber-mediated dorsal horn neuronal responses in conditions of neuropathy but not in sham operated rats and that non-noxious Aδ-mediated responses were not affected by SNX-482 [13] . In another study, mice lacking the α1E Ca 2+ channel subunit (required for functional expression of Cav2.3 channels) exhibited normal pain behavior against acute mechanical, thermal, and chemical stimuli; however, they showed reduced responses to somatic inflammatory pain [15] . Also, R-type Ca 2+ channels are located at primary synapses [27] and contributes to neurotransmitter release [28] . These results suggest that R-type Ca 2+ channels may play a dominant role in neuropathic pain rather than in normal physiological pain. Further work is required to elucidate role of Cav2.3e in the pathological pain conditions. In summary, our study provides the first evidence that two Cav2.3 isoforms are expressed in rat DRG neurons, a major isoform (Cav2.3e) and a minor isoform (Cav2.3a). The expression pattern of Cav2.3 isoforms suggests that Cav2.3e isoform of R-type Ca 2+ channels may be important in pain transmission and neuropathic pain both in DRG neurons and TG neurons. Therefore, Cav2.3e isoform in nociceptive neurons would be potential target for the pain treatment not only in the trigeminal system but also in the spinal system.
